Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Gastrointestinal CancerColorectal Cancer
Interventions
DIAGNOSTIC_TEST

Ultrasound - Serial and Tibial Nerve

Participants will undergo a serial and tibial nerve ultrasound

PROCEDURE

Skin Biopsy

Two skin biopsies will be obtained as 4.0 mm punch biopsies at distal end of leg in sural nerve territory (10 cm above lateral malleolus) and from the thigh

OTHER

Abbreviated Neurologic Exam

Exam to include strength assessment of the tibialis anterior and gastrocnemius and deep tendon reflex exam of the Achilles on the limb to be examined by nerve conduction velocity and ultrasound.

OTHER

Blood draw

12 ml blood sample will be taken

DIAGNOSTIC_TEST

Nerve Conduction Study

Sural and tibial nerve assessments

OTHER

QLQ-CIPN20 Questionnaire Administration

Self-reported neuropathy scoring questionnaire completed same day as blood draw.

Trial Locations (1)

27157

RECRUITING

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER